{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:25:13Z","timestamp":1781051113478,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013400","name":"National Research Center Kurchatov Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016971","name":"Lomonosov Moscow State University","doi-asserted-by":"publisher","award":["121,031,600,197\\u20135"],"award-info":[{"award-number":["121,031,600,197\\u20135"]}],"id":[{"id":"10.13039\/501100016971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xphs.2025.103944","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T15:56:28Z","timestamp":1754582188000},"page":"103944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Pluronic F68 and phospholipids liposomes modified with Pluronic F68 on the human neutrophils functional activity"],"prefix":"10.1016","volume":"114","author":[{"given":"Natalya","family":"Lotosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Marchenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya","family":"Shaposhnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Selishcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.xphs.2025.103944_bib0001","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.3390\/molecules26123610","article-title":"Polymeric drug delivery system based onpluronics for cancer treatment","volume":"26","author":"Yu","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.xphs.2025.103944_bib0002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.xphs.2025.103944_bib0003","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.3390\/pharmaceutics15082102","article-title":"Pluronic F-68 and F-127 based nanomedicines for advancing combination cancer therapy","volume":"15","author":"Khaliq","year":"2023","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.xphs.2025.103944_bib0004","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1021\/ma991634x","article-title":"Relationship between Pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes","volume":"33","author":"Kozlov","year":"2000","journal-title":"Macromolecules"},{"issue":"7","key":"10.1016\/j.xphs.2025.103944_bib0005","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/js960491e","article-title":"Pharmacokinetics of RheothRx injection in healthy male volunteers","volume":"86","author":"Jewell","year":"1997","journal-title":"J Pharm Sci"},{"issue":"17","key":"10.1016\/j.xphs.2025.103944_bib0006","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.286.17.2099","article-title":"Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial","volume":"286","author":"Orringer","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.xphs.2025.103944_bib0007","first-page":"2159","article-title":"Pharmacokinetics of a novel surface-active agent, purified poloxamer 188, in rat, rabbit, dog and man. Biopharmaceutics and Drug Disposition. 23(3), 87\u2013103","volume":"130","author":"Grindel","year":"2002","journal-title":"Polym Sci"},{"issue":"6","key":"10.1016\/j.xphs.2025.103944_bib0008","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1161\/01.CIR.90.6.2964","article-title":"Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F), a hemorheological agent that alters neutrophil function","volume":"90","author":"Schaer","year":"1994","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.xphs.2025.103944_bib0009","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.CIR.94.3.298","article-title":"Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial","volume":"94","author":"Schaer","year":"1996","journal-title":"Circulation"},{"issue":"30","key":"10.1016\/j.xphs.2025.103944_bib0010","doi-asserted-by":"crossref","first-page":"12287","DOI":"10.1523\/JNEUROSCI.5731-12.2013","article-title":"The membrane-active tri-block copolymer Pluronic F-68 profoundly rescues rat hippocampal neurons from oxygen\u2013glucose deprivation-induced death through early inhibition of apoptosis","volume":"33","author":"Shelat","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.xphs.2025.103944_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/srep18423","article-title":"Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan, and polyethylene glycol","volume":"6","author":"Farace","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xphs.2025.103944_bib0012","first-page":"1631","article-title":"Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes","volume":"69","author":"Smith","year":"1987","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.xphs.2025.103944_bib0013","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.surg.2008.05.001","article-title":"Effects of poloxamer 188 on human PMN cells","volume":"144","author":"Harting","year":"2008","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.xphs.2025.103944_bib0014","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/blood.V64.2.400.400","article-title":"Paralysis of phagocyte migration due to an artificial blood substitute","volume":"64","author":"Lane","year":"1984","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.103944_bib0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijpharm.2018.04.030","article-title":"Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases","volume":"545","author":"De Leo","year":"2018","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2025.103944_bib0016","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/acs.molpharmaceut.7b00374","article-title":"Pluronic P85\/F68 micelles of Baicalein could interfere with mitochondria to overcome MRP2-mediated efflux and offer improved anti-parkinsonian activity","volume":"14","author":"Chen","year":"2017","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2025.103944_bib0017","article-title":"Customized intranasal hydrogel delivering methylene blue ameliorates cognitive dysfunction against Alzheimer's disease","volume":"35","author":"Liu","year":"2023","journal-title":"Adv Mater"},{"issue":"5","key":"10.1016\/j.xphs.2025.103944_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267257","article-title":"Lung cancer targeting efficiency of Silibinin loaded poly Caprolactone\/Pluronic F68 Inhalable nanoparticles: in vitro and In vivo study","volume":"17","author":"Patel","year":"2022","journal-title":"Plos one"},{"issue":"3","key":"10.1016\/j.xphs.2025.103944_bib0019","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jconrel.2010.08.021","article-title":"Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy","volume":"148","author":"Oh","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2025.103944_bib0020","first-page":"114","article-title":"New concepts in colloid science: nano-adsorbent as a component of solution and adsorption protomicelles","volume":"512","author":"Ruslanov","year":"2023","journal-title":"Chem Mater Sci"},{"key":"10.1016\/j.xphs.2025.103944_bib0021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0003-2697(87)90157-6","article-title":"Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces","volume":"167","author":"Sackett","year":"1987","journal-title":"Anal, Biochem"},{"issue":"3","key":"10.1016\/j.xphs.2025.103944_bib0022","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/app.39426","article-title":"Effects of Pluronic F68 micellization on the viability of neuronal cells in culture","volume":"130","author":"Samith","year":"2013","journal-title":"J Appl"},{"issue":"2","key":"10.1016\/j.xphs.2025.103944_bib0023","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol, Rev"},{"issue":"9","key":"10.1016\/j.xphs.2025.103944_bib0024","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1023\/A:1018990706838","article-title":"Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm, Res"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.103944_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijpharm.2007.12.028","article-title":"Effect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism","volume":"356","author":"Huang","year":"2008","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2025.103944_bib0026","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejpb.2011.04.010","article-title":"Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers","volume":"79","author":"Fischer","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2025.103944_bib0027","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00024382-199503000-00001","article-title":"Postinjury neutrophil priming and activation states: therapeutic challenges","volume":"3","author":"Botha","year":"1995","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.xphs.2025.103944_bib0028","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0039-6060(05)80345-9","article-title":"Postinjury neutrophil priming and activation: an early vulnerable window","volume":"118","author":"Botha","year":"1995","journal-title":"Surgery"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925003983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925003983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:46:58Z","timestamp":1779857218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925003983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022354925003983"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103944","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Pluronic F68 and phospholipids liposomes modified with Pluronic F68 on the human neutrophils functional activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103944"}}